Request Free Sample ×
ReportInfographic

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

China Ascites Market

ID: MRFR/HC/54595-HCR
200 Pages
Satyendra Maurya
Last Updated: March 30, 2026

China Ascites Market Research Report: By Type (Transudative Ascites, Exudate Ascites), By Diagnosis (Ultrasound, CT Scan, Laparoscopy, Angiography), By Treatment (Surgeries) andBy End User (Hospitals & Clinics, Ambulatory Surgical Center, Diagnostic Centers)- Forecast to 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

China Ascites Market Infographic
Purchase Options
Compare License
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 China Ascites Market, BY Application (USD Million)
      1. 4.1.1 Diagnostic Procedures
      2. 4.1.2 Therapeutic Procedures
      3. 4.1.3 Research and Development
      4. 4.1.4 Clinical Trials
    2. 4.2 China Ascites Market, BY Type of Ascites (USD Million)
      1. 4.2.1 Malignant Ascites
      2. 4.2.2 Non-Malignant Ascites
      3. 4.2.3 Cirrhotic Ascites
      4. 4.2.4 Tuberculous Ascites
    3. 4.3 China Ascites Market, BY Treatment Method (USD Million)
      1. 4.3.1 Paracentesis
      2. 4.3.2 Diuretics
      3. 4.3.3 Transjugular Intrahepatic Portosystemic Shunt
      4. 4.3.4 Surgical Intervention
    4. 4.4 China Ascites Market, BY Patient Demographics (USD Million)
      1. 4.4.1 Age Group
      2. 4.4.2 Gender
      3. 4.4.3 Underlying Health Conditions
      4. 4.4.4 Socioeconomic Status
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the China Ascites Market
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the China Ascites Market
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Boehringer Ingelheim (DE)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Roche (CH)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Bristol-Myers Squibb (US)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Novartis (CH)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Gilead Sciences (US)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Merck & Co. (US)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 Amgen (US)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 AbbVie (US)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
      9. 5.2.9 Sanofi (FR)
        1. 5.2.9.1 Financial Overview
        2. 5.2.9.2 Products Offered
        3. 5.2.9.3 Key Developments
        4. 5.2.9.4 SWOT Analysis
        5. 5.2.9.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 CHINA MARKET ANALYSIS BY APPLICATION
    3. 6.3 CHINA MARKET ANALYSIS BY TYPE OF ASCITES
    4. 6.4 CHINA MARKET ANALYSIS BY TREATMENT METHOD
    5. 6.5 CHINA MARKET ANALYSIS BY PATIENT DEMOGRAPHICS
    6. 6.6 KEY BUYING CRITERIA OF CHINA ASCITES MARKET
    7. 6.7 RESEARCH PROCESS OF MRFR
    8. 6.8 DRO ANALYSIS OF CHINA ASCITES MARKET
    9. 6.9 DRIVERS IMPACT ANALYSIS: CHINA ASCITES MARKET
    10. 6.10 RESTRAINTS IMPACT ANALYSIS: CHINA ASCITES MARKET
    11. 6.11 SUPPLY / VALUE CHAIN: CHINA ASCITES MARKET
    12. 6.12 CHINA ASCITES MARKET, BY APPLICATION, 2024 (% SHARE)
    13. 6.13 CHINA ASCITES MARKET, BY APPLICATION, 2024 TO 2035 (USD Million)
    14. 6.14 CHINA ASCITES MARKET, BY TYPE OF ASCITES, 2024 (% SHARE)
    15. 6.15 CHINA ASCITES MARKET, BY TYPE OF ASCITES, 2024 TO 2035 (USD Million)
    16. 6.16 CHINA ASCITES MARKET, BY TREATMENT METHOD, 2024 (% SHARE)
    17. 6.17 CHINA ASCITES MARKET, BY TREATMENT METHOD, 2024 TO 2035 (USD Million)
    18. 6.18 CHINA ASCITES MARKET, BY PATIENT DEMOGRAPHICS, 2024 (% SHARE)
    19. 6.19 CHINA ASCITES MARKET, BY PATIENT DEMOGRAPHICS, 2024 TO 2035 (USD Million)
    20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 China MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY APPLICATION, 2026-2035 (USD Million)
      2. 7.2.2 BY TYPE OF ASCITES, 2026-2035 (USD Million)
      3. 7.2.3 BY TREATMENT METHOD, 2026-2035 (USD Million)
      4. 7.2.4 BY PATIENT DEMOGRAPHICS, 2026-2035 (USD Million)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

China Ascites Market Segmentation

China Ascites Market By Application (USD Million, 2022-2035)

  • Diagnostic Procedures
  • Therapeutic Procedures
  • Research and Development
  • Clinical Trials

China Ascites Market By Type of Ascites (USD Million, 2022-2035)

  • Malignant Ascites
  • Non-Malignant Ascites
  • Cirrhotic Ascites
  • Tuberculous Ascites

China Ascites Market By Treatment Method (USD Million, 2022-2035)

  • Paracentesis
  • Diuretics
  • Transjugular Intrahepatic Portosystemic Shunt
  • Surgical Intervention

China Ascites Market By Patient Demographics (USD Million, 2022-2035)

  • Age Group
  • Gender
  • Underlying Health Conditions
  • Socioeconomic Status

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories
Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization ✓ ✓ ✓
Direct Access to Analyst ✓ ✓ ✓
Deliverable Format ✓ ✓ ✓
Platform Access ✗ ✗ ✓
Discount on Next Purchase 10% 15% 15%
Printable Versions ✗ ✗ ✓